CERO logo

CERO Stock Overview

Profile

Full Name:

CERo Therapeutics Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 30, 2021

Indexes:

Not included

Website:

http://www.cero.bio

Description:

CERO Therapeutics Holdings focuses on developing innovative therapies for serious diseases. The company uses advanced technology to create treatments that target specific health issues, aiming to improve patient outcomes and enhance quality of life. Their research emphasizes precision medicine and cutting-edge solutions in healthcare.

Key Details

Price

$1.50

Market Cap

$4.54 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$130.44(-11.28% YoY)

PE Ratio

-

Annual ROE

33.92%

Annual Debt To Equity

-0.09

Beta

-0.19

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 8, 2025

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with CERO included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Healthcare sector
All stocks
NASDAQ Listed Companies
Biotechnology industry
Small cap stocks
Stocks with low beta
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.50
CERO price is $1.50

Price All-time High

$1132.00
CERO price is currently -99.87% below its historical high of $1132.00

Price Analysts Target

-
CERO price consensus analysts' forecast is unknown

Price Most Recent Change

+3.37%
CERO price was up +3.37% on Mar 7, 2025

Price YTD Change

-75.02%
CERO price is down -75.02% since January 1st

Price 3-Year Change

-99.85%
CERO price is down -99.85% over the past 3 years

Market cap

Market Cap

$4.54 M
CERO market capitalization is $4.54 million

Market Cap 3-Year Change

-
CERO market capitalization 3-year change is unknown

Market Cap All-time High

$116.48 M
CERO market capitalization is currently -96.10% below its historical high of $116.48 million

Market Cap Sector Rank

12.02%
CERO market capitalization is higher than 12.02% of companies in Healthcare sector

Technical

Beta

-0.19
CERO beta is -0.19

200-day SMA

$18.52
CERO price is currently -91.91% below its 200-day simple moving average

14-day RSI

34.51
CERO 14-day relative strength index is 34.51

30-day Relative Volume

0.11
CERO 30-day relative volume is 0.11

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
CERO annual revenue value is unknown

Annual Revenue Analysts Estimate

-
CERO annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
CERO annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
CERO annual revenue is unknown

Profit

Annual Gross Profit

-
CERO annual gross profit value is unknown

Annual Gross Margin

-
CERO annual gross profit margin value is unknown

Annual Operating Profit

-$11.97 M
CERO annual operating income is -$11.97 million

Annual Operating Margin

-
CERO annual operating profit margin value is unknown

Annual Net Income

-$11.83 M
CERO annual net profit is -$11.83 million

Annual Net Margin

-
CERO annual net profit margin value is unknown

EPS

Annual EPS

-$130.44
CERO annual earnings per share is -$130.44

Annual EPS Analysts Estimate

-
CERO annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-11.28%
CERO annual earnings per share is down -11.28% year-on-year

Annual EPS Sector Rank

2.88%
CERO annual earnings per share is higher than 2.88% of companies in Healthcare sector

ROA & ROE

Annual ROA

-104.23%
CERO annual return on assets is -104.23%

Annual ROE

33.92%
CERO annual return on equity is 33.92%

EBIT & EBITDA

Annual EBIT

-$11.97 M
CERO annual earnings before interest & taxes is -$11.97 million

Annual EBITDA

-$10.90 M
CERO annual EBITDA is -$10.90 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CERO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CERO price to earnings ratio is unknown

PB Ratio

PB Ratio

-0.62
CERO price to book ratio is -0.62

PB Ratio Sector Rank

10.38%
CERO price to book ratio is higher than 10.38% of companies in Healthcare sector

PS Ratio

PS Ratio

-
CERO price to sales ratio value is unknown

PS Ratio Sector Rank

-
CERO price to sales ratio is unknown

Enterprise value

Enterprise Value

$2.97 M
CERO enterprise value is $2.97 million

Enterprise Value Sector Rank

15.44%
CERO enterprise value is higher than 15.44% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.43
CERO EV/EBITDA is -0.43

EV/EBITDA Sector Rank

54.38%
CERO EV/EBITDA is higher than 54.38% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

6.08
CERO annual current ratio is 6.08

Annual Quick Ratio

-
CERO annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-0.09
CERO annual debt to equity ratio is -0.09

Annual Interest Coverage Ratio

-
CERO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CERO piotroski f-score value is unknown

Altman Z-Score

-
CERO altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$11.35 M
CERO annual total assets is $11.35 million

Annual Non Current Assets

$4.27 M
CERO annual long term assets is $4.27 million

Annual Current Assets

$7.08 M
CERO annual total current assets is $7.08 million

Annual Cash & Cash Equivalents

$6.82 M
CERO annual cash & cash equivalents is $6.82 million

Equity

Annual Book Value

-$34.87 M
CERO annual book value is -$34.87 million

Annual Working Capital

$5.91 M
CERO annual working capital is $5.91 million

Liabilities

Annual Total Liabilities

$46.22 M
CERO annual total liabilities is $46.22 million

Annual Total Long Term Liabilities

$45.06 M
CERO annual total long term liabilities is $45.06 million

Annual Current Liabilities

$1.16 M
CERO annual total current liabilities is $1.16 million

Annual Accounts Payable

$391.20 K
CERO annual accounts payable is $391.20 thousand

Debt

Annual Total Debt

$3.02 M
CERO annual total debt is $3.02 million

Annual Total Debt 1-Year Change

-16.25%
CERO annual total debt is down -16.25% year-on-year

Annual Long Term Debt

$2.34 M
CERO annual long term debt is $2.34 million

Annual Short Term Debt

$672.40 K
CERO annual short term debt is $672.40 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$11.97 M
CERO annual total expenses is $11.97 million

Annual Operating Expenses

$11.97 M
CERO annual total operating expenses is $11.97 million

Annual Cost Of Goods Sold

-
CERO annual cost of goods sold value is unknown

Annual SGA

$2.13 M
CERO annual SGA is $2.13 million

Annual D&A

$1.07 M
CERO annual depreciation & amortization is $1.07 million

Annual Interest Expense

-
CERO annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$11.71 M
CERO annual cash flow from operations is -$11.71 million

Annual CFO 1-Year Change

-16%
CERO annual cash flow from operations is down -16% year-on-year

Annual CFI

-$694.20 K
CERO annual cash flow from investing activities is -$694.20 thousand

Annual CFI 1-Year Change

-13.32%
CERO annual cash flow from investing activities is down -13.32% year-on-year

Annual CFF

$5600.00
CERO annual cash flow from financing activities is $5600.00

Annual CFF 1-Year Change

-90.71%
CERO annual cash flow from financing activities is down -90.71% year-on-year

Free CashFlow

Annual FCF

-$12.40 M
CERO annual free cash flow is -$12.40 million

Annual FCF 1-Year Change

-15.85%
CERO annual free cash flow is down -15.85% year-on-year

CAPEX

Annual CAPEX

-
CERO annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
CERO annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

SONN logo
Sonnet BioTherapeutics Holdings (SONN)
VRAY logo
ViewRay (VRAY)
SINT logo
Sintx Technologies (SINT)
CHEK logo
Check-Cap (CHEK)
ADIL logo
Adial Pharmaceuticals (ADIL)
GHSI logo
Guardion Health Sciences (GHSI)
ALLR logo
Allarity Therapeutics (ALLR)
KZIA logo
Kazia Therapeutics Limited (KZIA)
MSPR logo
MSP Recovery (MSPR)

FAQ

  • What is the ticker symbol for CERo Therapeutics Holdings?
  • Does CERo Therapeutics Holdings pay dividends?
  • What sector is CERo Therapeutics Holdings in?
  • What industry is CERo Therapeutics Holdings in?
  • What country is CERo Therapeutics Holdings based in?
  • When did CERo Therapeutics Holdings go public?
  • Is CERo Therapeutics Holdings in the S&P 500?
  • Is CERo Therapeutics Holdings in the NASDAQ 100?
  • Is CERo Therapeutics Holdings in the Dow Jones?
  • When does CERo Therapeutics Holdings report earnings?

What is the ticker symbol for CERo Therapeutics Holdings?

The ticker symbol for CERo Therapeutics Holdings is NASDAQ:CERO

Does CERo Therapeutics Holdings pay dividends?

No, CERo Therapeutics Holdings does not pay dividends

What sector is CERo Therapeutics Holdings in?

CERo Therapeutics Holdings is in the Healthcare sector

What industry is CERo Therapeutics Holdings in?

CERo Therapeutics Holdings is in the Biotechnology industry

What country is CERo Therapeutics Holdings based in?

CERo Therapeutics Holdings is headquartered in United States

When did CERo Therapeutics Holdings go public?

CERo Therapeutics Holdings's initial public offering (IPO) was on November 30, 2021

Is CERo Therapeutics Holdings in the S&P 500?

No, CERo Therapeutics Holdings is not included in the S&P 500 index

Is CERo Therapeutics Holdings in the NASDAQ 100?

No, CERo Therapeutics Holdings is not included in the NASDAQ 100 index

Is CERo Therapeutics Holdings in the Dow Jones?

No, CERo Therapeutics Holdings is not included in the Dow Jones index

When does CERo Therapeutics Holdings report earnings?

The date for CERo Therapeutics Holdings's next earnings report has not been announced yet